Hua Wang

Title: Innovations of Hua Wang in Cancer Research

Introduction

Hua Wang is an accomplished inventor based in Somerville, MA (US). She has made significant contributions to the field of cancer research through her innovative work on metabolic sugar precursors. Her research focuses on developing compounds that can selectively label and target cancer cells, enhancing the effectiveness of drug delivery systems.

Latest Patents

Hua Wang holds 1 patent for her invention titled "Trigger-activatable metabolic sugar precursors for cancer-selective labeling and targeting." This patent discloses compounds designed for the selective labeling of cell-surface sugars in cancer cells. The compounds are activatable by triggers specific to cancer cells, allowing for precise targeting. When metabolized, these compounds label a cancer cell surface sugar with an azide chemical group. This innovation facilitates a click chemistry reaction, enabling the combination of the cell surface-expressed azide with an alkynyl-drug conjugate. This process allows for efficient targeted drug delivery to cancer cells while reducing toxicity.

Career Highlights

Hua Wang is affiliated with the University of Illinois, where she continues her research and development in cancer-targeting technologies. Her work has garnered attention for its potential to improve cancer treatment outcomes through innovative drug delivery methods.

Collaborations

Hua Wang collaborates with Jianjun Cheng, who is also involved in cancer research. Their partnership enhances the scope and impact of their work in the field.

Conclusion

Hua Wang's innovative contributions to cancer research exemplify the potential of targeted therapies in improving treatment efficacy. Her work on metabolic sugar precursors represents a significant advancement in the quest for more effective cancer treatments.